Safety and Efficacy of Modern Stents in Patients with Metabolic Syndrome
The impact of metabolic syndrome (MS) on stent performance and outcomes of patients underwent percutaneous coronary intervention (PCI), including stent implantation, had not yet been fully established. The aim of the present study was to investigate long-term safety and efficacy of 2nd generation DE...
Main Authors: | Priscilla Pașc, Luciana Dobjanschi, Mihaela Zdrîncă, Marcel Zdrîncă, Liana Ștefan, Carmen Anca Huniadi, Marieta Lestyan, Florina Miere (Groza), Mircea Ioachim Popescu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/12/7/3277 |
Similar Items
-
Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01) -
Clinical Outcomes of Unprotected Left Main Coronary Artery Stenting in Nonsurgical Patients: A Single-Center Experience
by: John-Paul Pham, et al.
Published: (2014-08-01) -
Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
by: Talha Ahmed, et al.
Published: (2022-10-01) -
Association of stent diameter and target vessel revascularization in patients undergoing percutaneous coronary intervention: a secondary retrospective analysis based on a Chinese cohort study
by: Tiancheng Xu, et al.
Published: (2021-08-01) -
Cardiovascular outcomes associated with crush versus provisional stenting techniques for bifurcation lesions: a systematic review and meta-analysis
by: Feng Huang, et al.
Published: (2019-04-01)